Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 31 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11040970

    VMAT2 inhibitor compounds and compositions thereof

    Neurocrine Biosciences, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  2. US 11041000

    Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

    Protagonist Therapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  3. US 11040027

    Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  4. US 11040029

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  5. US 11034667

    Selective histone deacetylase inhibitors for the treatment of human disease

    Shuttle Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  6. US 11034672

    Tyrosine kinase inhibitor compositions, methods of making and methods of use

    Black Diamond Therapeutics, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  7. US 11033560

    Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  8. US 11034705

    Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  9. US 11033537

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Biomed Valley Discoveries, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  10. US 11028079

    Small molecule BET bromodomain inhibitors and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  11. US 11026905

    STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  12. US 11028120

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  13. US 11026931

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  14. US 11028083

    Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

    The Board of Regents of the University of Texas System · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  15. US 11028050

    Salts and polymorphs of a PDE4 inhibitor

    Tetra Discovery Partners · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  16. US 11026947

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  17. US 2021163596

    IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jun 3, 2021 · Expires May 29, 2041

    granted
  18. US 11021468

    TGF-ß inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  19. US 11021469

    Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same

    The Board of Regents of the University of Texas System · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  20. US 11020391

    CRMP2 sumoylation inhibitors and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  21. US 11021465

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  22. US 11021458

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  23. US 11013782

    Methods of treating chronic disorders with complement inhibitors

    Apellis Pharmaceuticals, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  24. US 11013740

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted